尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Somaiya Mayur Ian. Insider active across 1 company, notably NewAmsterdam Pharma Co N.V.. Aggregated, 4 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €145k. History available since 27 January 2025. The latest transaction was disclosed on 20 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Somaiya Mayur Ian is a declarant linked to NewAmsterdam Pharma Co N.V. as Chief Financial Officer. They have 4 filings in total, and in the sampled recent filings from 2025-01-07 to 2026-01-22, the sell amount is EUR 145389, with a modal transaction nature of Levée d'options.